Search for: "Novartis Ag" Results 421 - 440 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its application… [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
11 Jan 2008, 9:00 am
., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of Markush group language in the specification does not necessarily limit construction of claim terms: (Chicago IP Litigation),Coreg / Dilatrend / Eucardic (Carvedilol) - Teva Pharmaceutical Industries… [read post]
2 Oct 2008, 12:36 pm
Novartis Pharmaceuticals Corp., 283 F.3d 254, 266-68 (5th Cir. 2002), where the court didn't let the plaintiff get away with arguing that there should have been a warning about "liver failure" and "death" in addition to "hepatitis. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
10 Oct 2008, 3:22 pm
There is always an ounce of concern among manufacturers about consumer safety, and a pound of worry about the results of statistical risk benefit analyses attached to products. [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
26 May 2015, 7:42 am
(Emphasis added).FDA Regulation of Pharmacogenomic InformationWe still feel the same way, but now with the caveat that the FDA is starting to lay the regulatory foundation for drug warnings in the coming age of personalized medicine. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
2 Aug 2008, 12:54 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Discussion and analysis of WTO Ministerial meeting progress on TRIPs issues: (Intellectual Property Watch), (Intellectual Property Watch), (Intellectual Property Watch), (Intellectual Property Watch), (Intellectual Property Watch), (Intellectual Property Watch), (IP Updates), Italian broadcaster, Mediaset sues Google for hosting video clips on… [read post]
14 Aug 2011, 9:11 am by Schachtman
A recent editorial in the Annals of Occupational Hygiene is a poignant reminder of how oversold peer review is in the context of expert witness judicial gatekeeping. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
20 Jun 2008, 8:07 am
: (Electronic Frontier Foundation)   Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 23 June: US LSI: ‘Multilateral patents’ – San Francisco: (Patent Docs), 23 June: STEP / Committee on National Statistics conference on ‘Intangible assets: measuring and enhancing their contribution to corporate value and economic… [read post]
6 Jun 2008, 6:49 am
: (Spicy IP)   Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
29 Jan 2024, 4:35 pm
 Pix credit hereCates 1980 has distributed its February 2024 Report. [read post]
22 Jan 2009, 2:06 am
As we reported yesterday, the California Supreme Court denied the petitions for review in Wyeth v. [read post]